STW grant for Dömling and Meurs
15 April 2015
The Technology Foundation STW has granted Prof. Alexander Dömling (Drug Design group) and Prof. Herman Meurs (Molecular Pharmacology group) of the Groningen Research Institute of Pharmacy and Prof Philip Elsinga of the UMCG EUR 850,000 for their research proposal “Design, Synthesis and Validation of Potent and Isozyme Selective Arginase Inhibitors for Therapeutic Use in Asthma”. Industrial partners will invest an additional EUR 166.000,- in the project. The grant was awarded within the Open Technology programme. STW awarded seven research proposals in total.
| Last modified: | 08 September 2020 4.38 p.m. |
More news
-
12 September 2023
Art in times of AI
Leonardo Arriagada Beltran conducted his PhD research on the interface of computer-generated art and the constantly evolving field of Artificial Intelligence (AI). He will defend his Phd thesis on 21 September. His research offers valuable insights...
-
28 August 2023
Harish Vedantham and Casper van der Kooi nominated for 'Wetenschapstalent 2023'
Harish Vedantham and Casper van der Kooi have been nominated by New Scientist for Wetenschapstalent 2023 (Science Talent 2023). This election is meant to give young scientists and their research a stage.
-
26 July 2023
Five promising UG researchers to top institutes abroad on Rubicon grants
No less than five promising PhD graduates from the University of Groningen will be able to conduct research at top institutes abroad for two years thanks to the Rubicon programme organized by the Netherlands Organisation for Scientific Research...